These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37422377)

  • 1. Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study.
    Mac S; Shi S; Millson B; Tehrani A; Eberg M; Myageri V; Langley JM; Simpson S
    Vaccine; 2023 Aug; 41(35):5141-5149. PubMed ID: 37422377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
    Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
    CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.
    Shoukat A; Bawden CE; Röst G; LeBlanc JJ; Galvani AP; Langley JM; Moghadas SM
    Vaccine; 2024 Mar; 42(7):1768-1776. PubMed ID: 38368226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data.
    Pisesky A; Benchimol EI; Wong CA; Hui C; Crowe M; Belair MA; Pojsupap S; Karnauchow T; O'Hearn K; Yasseen AS; McNally JD
    PLoS One; 2016; 11(3):e0150416. PubMed ID: 26958849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
    Ares-Gómez S; Mallah N; Pardo-Seco J; Malvar-Pintos A; Pérez-Martínez O; Otero-Barrós MT; Súarez-Gaiche N; Santiago-Pérez MI; González-Pérez JM; López-Pérez LR; Rosón B; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F
    Pediatr Allergy Immunol; 2024 May; 35(5):e14131. PubMed ID: 38700124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study.
    Hartnett J; Donga P; Ispas G; Vandendijck Y; Anderson D; House S; Suner S
    Influenza Other Respir Viruses; 2022 Sep; 16(5):906-915. PubMed ID: 35474419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the Incidence of First RSV Hospitalization in Children Born in Ontario, Canada.
    Buchan SA; Chung H; To T; Daneman N; Guttmann A; Kwong JC; Murti M; Aryal G; Campigotto A; Chakraborty P; Gubbay J; Karnauchow T; Katz K; McGeer AJ; Dayre McNally J; Mubareka S; Richardson D; Richardson SE; Smieja M; Zahariadis G; Deeks SL
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):421-430. PubMed ID: 37335754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults.
    Branche AR; Saiman L; Walsh EE; Falsey AR; Jia H; Barrett A; Alba L; Phillips M; Finelli L
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1151-1160. PubMed ID: 36069297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the burden of adult hospitalized RSV infection using local and state data - methodology.
    Balasubramani GK; Nowalk MP; Eng H; Zimmerman RK
    Hum Vaccin Immunother; 2022 Dec; 18(1):1958610. PubMed ID: 35271432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups.
    Rafferty E; Paulden M; Buchan SA; Robinson JL; Bettinger JA; Kumar M; Svenson LW; MacDonald SE;
    Pharmacoeconomics; 2022 Jun; 40(6):633-645. PubMed ID: 35553028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.
    Demont C; Petrica N; Bardoulat I; Duret S; Watier L; Chosidow A; Lorrot M; Kieffer A; Lemaitre M
    BMC Infect Dis; 2021 Aug; 21(1):730. PubMed ID: 34340679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
    J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017-2019.
    Patel DA; Marcum ZA; Chansakul A; Toyip A; Nerney K; Panozzo CA; St Laurent S; Mehta D; Ghaswalla P
    Hum Vaccin Immunother; 2024 Dec; 20(1):2364493. PubMed ID: 38982719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between climate, geography and respiratory syncitial virus hospitalizations among children in Ontario, Canada: a population-based study.
    Radhakrishnan D; Ouedraogo A; Shariff SZ; McNally JD; Benchimol EI; Clemens KK
    BMC Infect Dis; 2020 Feb; 20(1):157. PubMed ID: 32075581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
    J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents.
    Bosco E; van Aalst R; McConeghy KW; Silva J; Moyo P; Eliot MN; Chit A; Gravenstein S; Zullo AR
    JAMA Netw Open; 2021 Jun; 4(6):e2111806. PubMed ID: 34106266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate post-discharge care among US adults hospitalized with respiratory syncytial virus infection.
    Sato R; Judy J; Yacisin K; Begier E; Sardana P; Agrawal N; Goswami A; Sharma M
    BMC Pulm Med; 2024 Oct; 24(1):486. PubMed ID: 39367363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.
    Matias G; Taylor R; Haguinet F; Schuck-Paim C; Lustig R; Shinde V
    BMC Public Health; 2017 Mar; 17(1):271. PubMed ID: 28320361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.